Cargando…
Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality
Background and objectives: Anabolic androgenic steroids (AAS) are mainly used for aesthetic and performance-enhancing reasons. Their use is a growing public health problem and concern for society because of their adverse effects. The primary aim of this study was to identify psychiatric and personal...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353874/ https://www.ncbi.nlm.nih.gov/pubmed/32481676 http://dx.doi.org/10.3390/medicina56060265 |
_version_ | 1783557975437213696 |
---|---|
author | Börjesson, Annica Möller, Christian Hagelin, Anders Vicente, Veronica Rane, Anders Lehtihet, Mikael Dahl, Marja-Liisa Gårevik, Nina Ekström, Lena |
author_facet | Börjesson, Annica Möller, Christian Hagelin, Anders Vicente, Veronica Rane, Anders Lehtihet, Mikael Dahl, Marja-Liisa Gårevik, Nina Ekström, Lena |
author_sort | Börjesson, Annica |
collection | PubMed |
description | Background and objectives: Anabolic androgenic steroids (AAS) are mainly used for aesthetic and performance-enhancing reasons. Their use is a growing public health problem and concern for society because of their adverse effects. The primary aim of this study was to identify psychiatric and personality disorders and to measure anxiety and depression in AAS users. Materials and Methods: Fifty-six males who actively contacted the Anti-Doping Hot-Line and wished to stop using AAS were included. Structured Clinical Interviews Diagnosis-I and -II were used to diagnose psychiatric and personality disorders. The Brief Scale for Anxiety and Montgomery Asberg Depression Rating Scale (subscales from the Comprehensive Psychopathological Rating Scale) were used to measure changes in anxiety and depression. Structured Clinical Interviews Diagnosis-I and -II were performed at one time point. Anxiety and depression were measured at inclusion and after six months. Urine samples were collected for an analysis of AAS and drugs of abuse. Results: All participants reported some adverse effects that they associated with AAS use. In total, 56% and 52% of the cohort fulfilled the criteria for Structured Clinical Interviews Diagnosis-I and -II diagnoses, respectively. A significantly increased risk of reporting aggressive feelings/behaviors (Odds Ratio (OR) = 4.9; Confidence Interval (CI) 0.99–25, p = 0.04), suicidal thoughts/attempts (OR = 4.6, CI 95; 0.99–21, p = 0.04) and criminality (OR = 6.5, CI 1–39, p = 0.03) was found among individuals with AAS use fulfilling the criteria for personality disorders compared with those without such AAS use. The Brief Scale for Anxiety score decreased from the median of 15 at inclusion to 10 at the follow-up visit six months later (p = 0.01, n = 19). Conclusions: Our findings indicate that among individuals with AAS use, those with a personality disorder report more aggressive behaviors, suicidal thoughts/suicidal attempts, and criminality than those without a personality disorder. |
format | Online Article Text |
id | pubmed-7353874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73538742020-07-21 Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality Börjesson, Annica Möller, Christian Hagelin, Anders Vicente, Veronica Rane, Anders Lehtihet, Mikael Dahl, Marja-Liisa Gårevik, Nina Ekström, Lena Medicina (Kaunas) Article Background and objectives: Anabolic androgenic steroids (AAS) are mainly used for aesthetic and performance-enhancing reasons. Their use is a growing public health problem and concern for society because of their adverse effects. The primary aim of this study was to identify psychiatric and personality disorders and to measure anxiety and depression in AAS users. Materials and Methods: Fifty-six males who actively contacted the Anti-Doping Hot-Line and wished to stop using AAS were included. Structured Clinical Interviews Diagnosis-I and -II were used to diagnose psychiatric and personality disorders. The Brief Scale for Anxiety and Montgomery Asberg Depression Rating Scale (subscales from the Comprehensive Psychopathological Rating Scale) were used to measure changes in anxiety and depression. Structured Clinical Interviews Diagnosis-I and -II were performed at one time point. Anxiety and depression were measured at inclusion and after six months. Urine samples were collected for an analysis of AAS and drugs of abuse. Results: All participants reported some adverse effects that they associated with AAS use. In total, 56% and 52% of the cohort fulfilled the criteria for Structured Clinical Interviews Diagnosis-I and -II diagnoses, respectively. A significantly increased risk of reporting aggressive feelings/behaviors (Odds Ratio (OR) = 4.9; Confidence Interval (CI) 0.99–25, p = 0.04), suicidal thoughts/attempts (OR = 4.6, CI 95; 0.99–21, p = 0.04) and criminality (OR = 6.5, CI 1–39, p = 0.03) was found among individuals with AAS use fulfilling the criteria for personality disorders compared with those without such AAS use. The Brief Scale for Anxiety score decreased from the median of 15 at inclusion to 10 at the follow-up visit six months later (p = 0.01, n = 19). Conclusions: Our findings indicate that among individuals with AAS use, those with a personality disorder report more aggressive behaviors, suicidal thoughts/suicidal attempts, and criminality than those without a personality disorder. MDPI 2020-05-28 /pmc/articles/PMC7353874/ /pubmed/32481676 http://dx.doi.org/10.3390/medicina56060265 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Börjesson, Annica Möller, Christian Hagelin, Anders Vicente, Veronica Rane, Anders Lehtihet, Mikael Dahl, Marja-Liisa Gårevik, Nina Ekström, Lena Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality |
title | Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality |
title_full | Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality |
title_fullStr | Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality |
title_full_unstemmed | Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality |
title_short | Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality |
title_sort | male anabolic androgenic steroid users with personality disorders report more aggressive feelings, suicidal thoughts, and criminality |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353874/ https://www.ncbi.nlm.nih.gov/pubmed/32481676 http://dx.doi.org/10.3390/medicina56060265 |
work_keys_str_mv | AT borjessonannica maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT mollerchristian maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT hagelinanders maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT vicenteveronica maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT raneanders maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT lehtihetmikael maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT dahlmarjaliisa maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT gareviknina maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality AT ekstromlena maleanabolicandrogenicsteroiduserswithpersonalitydisordersreportmoreaggressivefeelingssuicidalthoughtsandcriminality |